KK Women's and Children's Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Singapore Singapore (1858)

Organization Overview

First Clinical Trial
2003
NCT00299754
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

CMB, KK Hospital | Consultant at KK Women's and Children's Hospital, Singapore | KK Women's and Children's Hospital | KK Women's and Children's Hospital, BMTCT | KK Women's and Children's Hospital (KKH) | KK Women's and Children's Hospital, Singapore | KK Women's and Children's Hospital, SingHealth | KK Women's & Children's Hospital, SINGAPORE

Active Ingredients

Drugs in Phase 4 Trials (10)

alprostadil (prostin) (1 trial)

bnt162b2 (Comirnaty) (2 trials)

dexmedetomidine (precedex) (2 trials)

ibuprofen (motrin) (2 trials)

indomethacin (indocin) (1 trial)

letrozole (femara) (2 trials)

levobupivacaine (chirocaine) (1 trial)

mifepristone (mifeprex) (1 trial)

remifentanil (ultiva) (4 trials)

ropivacaine (naropin) (4 trials)

Drugs in Phase 3 Trials (17)

atropine (1 trial)

cabergoline (dostinex) (1 trial)

diphenoxylate (1 trial)

ephedrine (3 trials)

fentanyl (Innovar) (3 trials)

meperidine (demerol) (1 trial)

misoprostol (cytotec) (1 trial)

morphine (3 trials)

mrna-1273 (Spikevax) (1 trial)

neostigmine (bloxiverz) (1 trial)

nitrous oxide (1 trial)

oxycodone (oxycontin) (1 trial)

phenylephrine (Prefrin) (3 trials)

prasterone (intrarosa) (1 trial)

sevoflurane (ultane) (1 trial)

sugammadex (bridion) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Phase 2 Trials (7)

allogeneic natural killer cells (1 trial)

cd19 car-t cells (1 trial)

esketamine (spravato) (1 trial)

norgestrel (Ovral) (1 trial)

propofol (diprivan) (1 trial)

sars-cov-2 specific t cells (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Phase 1 Trials (2)

autologous umbilical cord blood (1 trial)

cyclopentolate (cyclogyl) (1 trial)

Drugs in Other Trials (9)

acetaminophen (tylenol) (1 trial)

carboplatin (paraplatin) (1 trial)

glycerin (1 trial)

ketamine (ketalar) (1 trial)

paclitaxel (taxol) (1 trial)

pertuzumab (perjeta) (1 trial)

trastuzumab (herceptin) (1 trial)

vitamin c (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Azoospermia (Phase 3)

Birth Weight (Phase 4)

Brain Diseases (Phase 1)

Brain Ischemia (Phase 1)

Breakthrough Pain (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 2)

Depression (Phase 3)

Depressive Disorder (Phase 2)

Ductus Arteriosus, Patent (Phase 4)

Fallopian Tube Neoplasms (Phase 2)

Hemorrhage (Phase 3)

Hernia (Phase 3)

Hernia, Inguinal (Phase 3)

Hypotension (Phase 3)

Hypoxia (Phase 1)

Hypoxia-Ischemia, Brain (Phase 1)

Infertility (Phase 3)

Ischemia (Phase 1)

Labor Pain (Phase 4)

Myopia (Phase 1)

Nausea (Phase 3)

Neurodevelopmental Disorders (Phase 3)

Oligospermia (Phase 3)

Ovarian Hyperstimulation Syndrome (Phase 3)

Ovarian Neoplasms (Phase 2)

Postoperative Nausea and Vomiting (Phase 3)

Postpartum Hemorrhage (Phase 3)

Pruritus (Phase 3)

Refractive Errors (Phase 1)

Respiratory Insufficiency (Phase 3)

Rhabdomyosarcoma (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Ewing (Phase 2)

Syndrome (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 36
  • # of Trial APIs: 45